Novo Nordisk has officially launched Ozempic in India, marking a significant expansion of its presence in one of the world’s fastest-growing markets for diabetes and obesity treatments. The launch comes at a time when demand for weight-loss drugs is rising sharply, driven by lifestyle changes, urbanisation, and increasing awareness of…
In Venezuela, money does not enter the economy as a steady stream. Instead, it arrives in bursts, timed to…
Russian seaborne oil product exports dipped slightly in November, falling 0.8% from October to 7.494 million metric tons, according…
US equities are set to reach fresh record highs next year, supported by stronger corporate earnings, broadening artificial intelligence…
Argentina’s November inflation data reflect a familiar tension between rising food prices and the effects of an aggressive austerity…
GameStop (NYSE: GME) – the poster child of meme stock mania – is struggling to reinvent itself.On Wednesday, the…
Europe’s news flow today is a mix of corporate shake-ups, political tension, and cautious market mood. Amazon’s hefty tax…
Uber Technologies (NYSE: UBER) is inching down on Wednesday morning as a wave of protests in Europe signalled growing…
Markets are bracing for a pivotal Fed decision, with a widely expected rate cut setting the tone for a…
